Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Dec 5, 2016 at 11:35 AM EST

EyeGate Pharmaceuticals Continues to Win in Mid-Stage Trial

EyeGate Pharmaceuticals shares rose about 10% on Monday after the company announced promising data from its mid-stage trial of its…

Chris Lange | Dec 5, 2016 at 11:05 AM EST

NeuroDerm Jumps on Critical FDA Update

NeuroDerm has announced that it intends to pursue a comparative bioavailability regulatory path for the its lead product candidate ND0612…

Chris Lange | Dec 5, 2016 at 9:35 AM EST

GW Pharmaceuticals Shows Smaller Than Expected Q4 Loss

GW Pharmaceuticals reported its fiscal fourth-quarter financial results before the markets opened on Monday.

Chris Lange | Dec 5, 2016 at 8:40 AM EST

Cempra Rises on Late-Stage Trial

Shares of Cempra saw a handy gain early Monday after Toyama Chemical announced that it had begun Phase 3 clinical…

Lee Jackson | Dec 5, 2016 at 8:20 AM EST

4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential

These are stocks that make good sense for investors looking to add to their overall equity holdings. They are all…

Douglas A. McIntyre | Dec 3, 2016 at 8:40 AM EST

Health Care Spending Reaches $3.2 Trillion, Nearly $10,000 per Person

Health care costs are on a rapid upturn, and with a vengeance, reaching $3.2 trillion in 2015. Affordability is at…

Chris Lange | Dec 2, 2016 at 11:10 AM EST

Envision Healthcare Triples on Completed Merger

These health care companies are looking to form one of the nation’s largest provider organizations in an effort to help…

Lee Jackson | Dec 1, 2016 at 8:10 AM EST

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for…

Chris Lange | Nov 29, 2016 at 3:44 PM EST

FDA Requests Additional Data on Amicus’ Fabry Disease Treatment

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is watching its shares drop on Tuesday after the company provided an update on its…

Chris Lange | Nov 29, 2016 at 2:58 PM EST

Nivalis Therapeutics Crumbles on Failed Mid-Stage Trial

Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is watching its shares crumble on Tuesday after the company gave an update on its…

Chris Lange | Nov 29, 2016 at 12:20 PM EST

Genetic Technologies Practically Doubles on Licensing Agreement

Shares of Genetic Technologies practically doubled in Tuesday's session after the company announced the signing of an exclusive worldwide license…

Chris Lange | Nov 29, 2016 at 10:05 AM EST

Cotiviti Gears Up for Secondary Offering

Cotiviti intends to offer 10 million shares in a secondary offering that could be valued up to more than $361…

Chris Lange | Nov 28, 2016 at 12:20 PM EST

Recro Pharma Rises on Late Stage Win

Recro Pharma shares saw a handy gain on Monday after the company announced positive late-stage results on its acute postoperative…

Chris Lange | Nov 28, 2016 at 11:35 AM EST

PhaseRx More Than Doubles on Key FDA Approval

Shares of PhaseRx more than doubled on Monday after the company announced that it received a key FDA approval for…

Chris Lange | Nov 28, 2016 at 7:35 AM EST

Short Sellers Grow More Aggressive on Major Biotechs

The November 15 short interest data have been compared with the previous report, and short interest increased in most of…

1 … 182 183 184 185 186 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

EyeGate Pharmaceuticals Continues to Win in Mid-Stage Trial

NeuroDerm Jumps on Critical FDA Update

GW Pharmaceuticals Shows Smaller Than Expected Q4 Loss

Cempra Rises on Late-Stage Trial

4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential

Health Care Spending Reaches $3.2 Trillion, Nearly $10,000 per Person

Envision Healthcare Triples on Completed Merger

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

FDA Requests Additional Data on Amicus’ Fabry Disease Treatment

Nivalis Therapeutics Crumbles on Failed Mid-Stage Trial

Genetic Technologies Practically Doubles on Licensing Agreement

Cotiviti Gears Up for Secondary Offering

Recro Pharma Rises on Late Stage Win

PhaseRx More Than Doubles on Key FDA Approval

Short Sellers Grow More Aggressive on Major Biotechs

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

EyeGate Pharmaceuticals Continues to Win in Mid-Stage Trial

NeuroDerm Jumps on Critical FDA Update

GW Pharmaceuticals Shows Smaller Than Expected Q4 Loss

Cempra Rises on Late-Stage Trial

4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential

Health Care Spending Reaches $3.2 Trillion, Nearly $10,000 per Person

Envision Healthcare Triples on Completed Merger

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

FDA Requests Additional Data on Amicus’ Fabry Disease Treatment

Nivalis Therapeutics Crumbles on Failed Mid-Stage Trial

Genetic Technologies Practically Doubles on Licensing Agreement

Cotiviti Gears Up for Secondary Offering

Recro Pharma Rises on Late Stage Win

PhaseRx More Than Doubles on Key FDA Approval

Short Sellers Grow More Aggressive on Major Biotechs

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check